期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

MINE方案治疗难治性与复发性中、高度恶性非霍奇金淋巴瘤的临床观察 被引量：5

下载PDF
导出
摘要 非霍奇金淋巴瘤（non—Hodgkin’s lymphoma，NHL）是起源于淋巴结或其他淋巴组织的恶性肿瘤，联合化疗是治疗进展期NHL的主要治疗方式。传统CHOP方案（环磷酰胺、多柔比星、长春新碱、泼尼松）至今仍被认为是治疗中、高度恶性NHL标准的一线化疗方案，其治愈率可达40％，但仍有50％～60％的患者治疗后不能缓解或缓解后复发。
作者 杨升 卢辉山 郑知文 张祥福 赖金火 侯培峰 郑建伟 林碧娟
机构地区 福建医科大学附属协和医院肿瘤科
出处 《中国癌症杂志》 CAS CSCD 北大核心 2009年第8期641-643,共3页 China Oncology
关键词 非霍奇金淋巴瘤 化疗疗法 解救治疗 MINE方案
分类号 R733.4 [医药卫生—肿瘤] R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1Aurer I, Mitrovic Z, Nemet D, et al. Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE [ J ] . J Chemother, 2008, 20:640-644.
  • 2Oyan B, Koc Y, Ozdemir E, et al. Ifosfamide idarubicin and etoposide in relapsed refractory Hodgkin disease or non Hodgkin lymphoma a salvage regimen with high response rates before autologous stem cell transplantation [ J ] . J Biol Blood Marrow Transplant, 2005, 119:688-697.
  • 3Rodriguez MA, Cabanillas FC, Hagemeister FB, et al. A phase Ⅱ trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas [ J ] . Ann Oncol, 1995, 6:609-611.
  • 4The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma [ J ] . N Engl J Med, 1993, 329: 987-993.
  • 5张明智,臧卫平,宋敏,耿丽,李鑫,王瑞林.DACE方案治疗难治复发性非霍奇金淋巴瘤的临床疗效[J].癌症,2008,27(4):435-437. 被引量：9
  • 6Jo JC, Kang BW, Jang G, et al. BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity [ J ] . Ann Hematol, 2008, 87:43-48.
  • 7Ogura M, Morishima Y, Kagami Y, et al. Randomized phase Ⅱ study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma [ J ] . Cancer Sci, 2006, 97:305-312.
  • 8Rodriguez-Monge E J, Cabanillas F. Long-term follow-up of platinum-based lymphoma salvage regimens. The MD Anderson Cancer Center experience [ J ] . Hematol Oncol Clin North Am, 1997, 11: 937-947.
  • 9Mayer J, V a soy a I, Kor i stek Z, et al. Ifosfamide and etoposide-based hemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma [ J ] . Eur J Haematol, 2001, 64:21-27.
  • 10范云,黄志煜,罗吕宏,余海峰.MINE方案治疗复发或耐药的侵袭性淋巴瘤临床观察[J].癌症,2005,24(12):1503-1506. 被引量：16

二级参考文献16

  • 1周生余,石远凯,何小慧,张频,董梅,黄鼎智,杨建良,张长弓,刘鹏,杨晟,冯奉仪.DICE方案治疗复发或耐药中高度恶性非霍奇金淋巴瘤[J].癌症,2005,24(4):465-469. 被引量：29
  • 2Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimen for advanced non-Hodgkin's lymphoma [J]. N Engl J Med, 1993,328(14): 1002-1006.
  • 3Velasquez WS, Cabanillas F, Salvador P, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) [J]. Blood,1988,71 ( 1 ): 117-122.
  • 4Coleman M, Leonard J, Shuster MW, et al. DICE(dexamethasone, ifosfamide, cisplatine, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin'slymphoma (NHL) [J]. Eur J Haematol, 2001,64:41-45.
  • 5Wilder DD, Ogden JL, Jain VK, et al. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma [J]. Clin Lymphoma, 2001,1 (4): 285-292.
  • 6Rodriguez MA, Cabanillas FC, Hagemeister FB, et al. A phase Ⅱ trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas [ J ]. Ann Oncol, 1995,6 (6): 609-611.
  • 7The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma [J]. N Engl J Med, 1993,329(14):987-993
  • 8Mayer J, Vasova I, Koristek Z, et al. Ifosfamide- and etoposidebased chemotherapy as salve and mobilizing regimens for poorprognosis lymphoma [ J ]. Eur J Haematol Suppl, 2001,64: 21 -27.
  • 9Emmanouilides C, Lill M, Telatar M, et al. Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma [J]. Clin Lymphoma, 2002,3 (2): 111 - 116.
  • 10Fisher R I, Gaynor E R, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma [J]. N Engl J Med, 1993,328(14) : 1002-1006.

共引文献23

同被引文献42

  • 1Sheng-Hsuan Chen,Gi-Shih Lien,Yuarn-Jang Lee,Horng-Yuan Lou,Ching-Ruey Hsieh,Chia-Lang Fang,Shiann Pan.Anti-Helicobacter pylori therapy significantly reduces Helicobacter py/ori-Induced gastric mucosal damage in Mongolian gerbils[J].World Journal of Gastroenterology,2005,11(7):982-985. 被引量：6
  • 2范云,黄志煜,罗吕宏,余海峰.MINE方案治疗复发或耐药的侵袭性淋巴瘤临床观察[J].癌症,2005,24(12):1503-1506. 被引量：16
  • 3林峰,赵晖,孙元珏,姚阳.MINE方案治疗复发难治性非霍奇金淋巴瘤23例[J].肿瘤防治研究,2007,34(1):57-58. 被引量：1
  • 4罗盛,陈怡,俞康,胡旭东,孙岚.MINE方案治疗难治性侵袭性非霍奇金淋巴瘤的临床研究[J].中国热带医学,2007,7(3):367-368. 被引量：3
  • 5孙燕,石远凯.临床肿瘤内科手册[M].第5版,北京:人民卫生出版社,2008:711-717.
  • 6Oyan B,Koc Y,Ozdemir E,et al.Ifosfamide idarubicin and etoposide in relapsed refractory Hodgkin disease or non Hodgkin lymphoma asalvage regimen with high response rates before autologous stem cell transplantation[J].J Biol Blood Marrow Transplant,2005,11(9):688.
  • 7Jo JC,Kang BW,Jang G,et al.BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hedskin's lymphoma patients:comparative analysis of efficacy and toxicity[J].Ann Hematol,2008,87(1):43.
  • 8Berdeja JG,Hess A,Lucas DM,et al.Systemic interleukin-2 and adoptive transfer of lymphokine-activatad killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab[J].Clin Cancer Res,2007,13(8):2392.
  • 9Rodriguez J,Conde E,Gutierrez A,et al.The adjusted International Prognostic Index and beta-2-micrnglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma[J].Haemotologica,2007,92(8):1067.
  • 10Seki R,Ohshima K,Fujisaki T. Prognostic impact of immunohisto- chemical biomarkers in diffuse large B-cell lymphoma in the Rituximab era[J].{H}CANCER SCIENCE,2009,(10):1842-1847.

引证文献5

二级引证文献16

中国癌症杂志
2009年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部